Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MESOTHELIOMA, . Treffer: 51

2020

Bilecz, A; Stockhammer, P; Theegarten, D; Kern, I; Jakopovic, M; Samarzija, M; Klikovits, T; Hoda, MA; Döme, B; Oberndorfer, F; Muellauer, L; Fillinger, J; Kovács, I; Pirker, C; Schuler, M; Plönes, T; Aigner, C; Klepetko, W; Berger, W; Brcic, L; Laszlo, V; Hegedus, B Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma.
Histopathology. 2020;
Web of Science PubMed FullText FullText_MUG

 

Brcic, L; Kern, I Clinical significance of histologic subtyping of malignant pleural mesothelioma.
Transl Lung Cancer Res. 2020; 9(3): 924-933. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Galateau Salle, F; Le Stang, N; Tirode, F; Courtiol, P; Nicholson, AG; Tsao, MS; Tazelaar, HD; Churg, A; Dacic, S; Roggli, V; Pissaloux, D; Maussion, C; Moarii, M; Beasley, MB; Begueret, H; Chapel, DB; Copin, MC; Gibbs, AR; Klebe, S; Lantuejoul, S; Nabeshima, K; Vignaud, JM; Attanoos, R; Brcic, L; Capron, F; Chirieac, LR; Damiola, F; Sequeiros, R; Cazes, A; Damotte, D; Foulet, A; Giusiano-Courcambeck, S; Hiroshima, K; Hofman, V; Husain, AN; Kerr, K; Marchevsky, A; Paindavoine, S; Picquenot, JM; Rouquette, I; Sagan, C; Sauter, J; Thivolet, F; Brevet, M; Rouvier, P; Travis, WD; Planchard, G; Weynand, B; Clozel, T; Wainrib, G; Fernandez-Cuesta, L; Pairon, JC; Rusch, V; Girard, N Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center.
J Thorac Oncol. 2020; 15(6):1037-1053
PubMed FullText FullText_MUG

 

Nicholson, AG; Sauter, JL; Nowak, AK; Kindler, HL; Gill, RR; Remy-Jardin, M; Armato, SG; Fernandez-Cuesta, L; Bueno, R; Alcala, N; Foll, M; Pass, H; Attanoos, R; Baas, P; Beasley, MB; Brcic, L; Butnor, KJ; Chirieac, LR; Churg, A; Courtiol, P; Dacic, S; De Perrot, M; Frauenfelder, T; Gibbs, A; Hirsch, FR; Hiroshima, K; Husain, A; Klebe, S; Lantuejoul, S; Moreira, A; Opitz, I; Perol, M; Roden, A; Roggli, V; Scherpereel, A; Tirode, F; Tazelaar, H; Travis, WD; Tsao, MS; van Schil, P; Vignaud, JM; Weynand, B; Lang-Lazdunski, L; Cree, I; Rusch, VW; Girard, N; Galateau-Salle, F EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
J Thorac Oncol. 2020; 15(1):29-49 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pirker, C; Bilecz, A; Grusch, M; Mohr, T; Heidenreich, B; Laszlo, V; Stockhammer, P; Lötsch-Gojo, D; Gojo, J; Gabler, L; Spiegl-Kreinecker, S; Dome, B; Steindl, A; Klikovits, T; Hoda, MA; Jakopovic, M; Samarzija, M; Mohorcic, K; Kern, I; Kiesel, B; Brcic, L; Oberndorfer, F; Müllauer, L; Klepetko, W; Schmidt, WM; Kumar, R; Hegedus, B; Berger, W Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Clin Cancer Res. 2020; 26(14):3819-3830
PubMed FullText FullText_MUG

 

Sadiku-Zehri, F; Gamulin, O; Škrabić, M; Qerimi-Krasniqi, A; Sedliž, F; Šepac, A; Brčić, L; Batelja Vuletić, L; Seiwerth, S EXPRESS: Differentiating Between Malignant Mesothelioma and Other Pleural Lesions Using Fourier Transform Infrared Spectroscopy.
Appl Spectrosc. 2020; 3702820924726-3702820924726.
Web of Science PubMed FullText FullText_MUG

 

2019

Opitz, I; Bille, A; Tsourti, Z; Nakaerts, K; Ampollini, L; De Perrot, M; Brcic, L; Nadal, E; Gray, S; Aerts, J; Verbeken, E; Silini, E; Zaeimi, F; Samarzija, M; Llatjos, R; Tsimpoukis, S; van der Thusen, JH; Finn, S; Marti, N; Dimopoulou, G; Monkhorst, K; Brunello, A; Kammler, R; Soltermann, A; Falcoz, P; Baas, P; Stahel, R; Mesoscape, FE; Consortia, FE Realtime Data from Europe ETOP / ESTS Database
J THORAC ONCOL. 2019; 14(10):S93-S94.-IASLC 2019 World Conference on Lung Cancer; SEP 7-10, 2019; Barcelona, SPAIN. [Oral Communication]
Web of Science FullText FullText_MUG

 

2018

Brcic, L; Vlacic, G; Quehenberger, F; Kern, I Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
Arch Pathol Lab Med. 2018; 142(6):747-752 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Davidson, B; Pinamonti, M; Cuevas, D; Holth, A; Zeppa, P; Hager, T; Wohlschlaeger, J; Tötsch, M The diagnostic role of PTEN and ARID1A in serous effusions.
Virchows Arch. 2018; 472(3):425-432
Web of Science PubMed FullText FullText_MUG

 

Davidson, B; Tötsch, M; Wohlschlaeger, J; Hager, T; Pinamonti, M The diagnostic role of BAP1 in serous effusions.
Hum Pathol. 2018; 79(6):122-126
Web of Science PubMed FullText FullText_MUG

 

Mašić, S; Brčić, L; Krušlin, B; Šepac, A; Pigac, B; Stančić-Rokotov, D; Jakopović, M; Seiwerth, S Expression of plakophilin 3 in diffuse malignant pleural mesothelioma.
Histol Histopathol. 2018; 103(7):11996-11996
Web of Science PubMed FullText FullText_MUG

 

Rosen, LE; Karrison, T; Ananthanarayanan, V; Gallan, AJ; Adusumilli, PS; Alchami, FS; Attanoos, R; Brcic, L; Butnor, KJ; Galateau-Sallé, F; Hiroshima, K; Kadota, K; Klampatsa, A; Stang, NL; Lindenmann, J; Litzky, LA; Marchevsky, A; Medeiros, F; Montero, MA; Moore, DA; Nabeshima, K; Pavlisko, EN; Roggli, VL; Sauter, JL; Sharma, A; Sheaff, M; Travis, WD; Vigneswaran, WT; Vrugt, B; Walts, AE; Tjota, MY; Krausz, T; Husain, AN Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
Mod Pathol. 2018; 31(4):598-606 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schelch, K; Wagner, C; Hager, S; Pirker, C; Siess, K; Lang, E; Lin, R; Kirschner, MB; Mohr, T; Brcic, L; Marian, B; Holzmann, K; Grasl-Kraupp, B; Krupitza, G; Laszlo, V; Klikovits, T; Dome, B; Hegedus, B; Garay, T; Reid, G; van Zandwijk, N; Klepetko, W; Berger, W; Grusch, M; Hoda, MA FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.
Carcinogenesis. 2018; 39(4): 534-545. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Walpole, S; Pritchard, AL; Cebulla, CM; Pilarski, R; Stautberg, M; Davidorf, FH; de la Fouchardière, A; Cabaret, O; Golmard, L; Stoppa-Lyonnet, D; Garfield, E; Njauw, CN; Cheung, M; Turunen, JA; Repo, P; Järvinen, RS; van Doorn, R; Jager, MJ; Luyten, GPM; Marinkovic, M; Chau, C; Potrony, M; Höiom, V; Helgadottir, H; Pastorino, L; Bruno, W; Andreotti, V; Dalmasso, B; Ciccarese, G; Queirolo, P; Mastracci, L; Wadt, K; Kiilgaard, JF; Speicher, MR; van Poppelen, N; Kilic, E; Al-Jamal, RT; Dianzani, I; Betti, M; Bergmann, C; Santagata, S; Dahiya, S; Taibjee, S; Burke, J; Poplawski, N; O'Shea, SJ; Newton-Bishop, J; Adlard, J; Adams, DJ; Lane, AM; Kim, I; Klebe, S; Racher, H; Harbour, JW; Nickerson, ML; Murali, R; Palmer, JM; Howlie, M; Symmons, J; Hamilton, H; Warrier, S; Glasson, W; Johansson, P; Robles-Espinoza, CD; Ossio, R; de Klein, A; Puig, S; Ghiorzo, P; Nielsen, M; Kivelä, TT; Tsao, H; Testa, JR; Gerami, P; Stern, MH; Paillerets, BB; Abdel-Rahman, MH; Hayward, NK Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
JNCI-J NATL CANCER I. 2018; 110(12): 1328-1341. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Arzt, L; Halbwedl, I; Gogg-Kamerer, M; Popper, HH Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
Pathol Oncol Res. 2017; 23(3):595-605 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dong, YW; Zhang, H; Schelch, K; Klikovits, T; Stockhammer, P; Jakopovic, M; Samarzija, M; Brcic, L; Reid, G; Kirschner, M; Kao, S; Opitz, I; Weder, W; Frauenfelder, T; Linh, NKTD; Klepetko, W; Van Zandwijk, N; Hegedus, B; Berger, W; Dome, B; Laszlo, V; Grusch, M; Hoda, M Circulating Fibroblast Growth Factor 18 is Elevated in Malignant Pleural Mesothelioma Patients - A Multi-Institutional Study
J THORAC ONCOL. 2017; 12(1):S247-S248.-IASLC 17th World Conference on Lung Cancer; DEC 4-7, 2016; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Hendry, S; Salgado, R; Gevaert, T; Russell, PA; John, T; Thapa, B; Christie, M; van de Vijver, K; Estrada, MV; Gonzalez-Ericsson, PI; Sanders, M; Solomon, B; Solinas, C; Van den Eynden, GGGM; Allory, Y; Preusser, M; Hainfellner, J; Pruneri, G; Vingiani, A; Demaria, S; Symmans, F; Nuciforo, P; Comerma, L; Thompson, EA; Lakhani, S; Kim, SR; Schnitt, S; Colpaert, C; Sotiriou, C; Scherer, SJ; Ignatiadis, M; Badve, S; Pierce, RH; Viale, G; Sirtaine, N; Penault-Llorca, F; Sugie, T; Fineberg, S; Paik, S; Srinivasan, A; Richardson, A; Wang, Y; Chmielik, E; Brock, J; Johnson, DB; Balko, J; Wienert, S; Bossuyt, V; Michiels, S; Ternes, N; Burchardi, N; Luen, SJ; Savas, P; Klauschen, F; Watson, PH; Nelson, BH; Criscitiello, C; O'Toole, S; Larsimont, D; de Wind, R; Curigliano, G; Andre, F; Lacroix-Triki, M; van de Vijver, M; Rojo, F; Floris, G; Bedri, S; Sparano, J; Rimm, D; Nielsen, T; Kos, Z; Hewitt, S; Singh, B; Farshid, G; Loibl, S; Allison, KH; Tung, N; Adams, S; Willard-Gallo, K; Horlings, HM; Gandhi, L; Moreira, A; Hirsch, F; Dieci, MV; Urbanowicz, M; Brcic, I; Korski, K; Gaire, F; Koeppen, H; Lo, A; Giltnane, J; Rebelatto, MC; Steele, KE; Zha, JP; Emancipator, K; Juco, JW; Denkert, C; Reis, J; Loi, S; Fox, SB Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
ADV ANAT PATHOL. 2017; 24(6): 311-335. [OPEN ACCESS]
Web of Science PubMed PUBMED Central

 

Mairinger, FD; Vollbrecht, C; Flom, E; Christoph, DC; Schmid, KW; Kollmeier, J; Popper, HH; Mairinger, T; Walter, RFH Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Oncotarget. 2017; 8(23):37502-37510 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Geltner, C; Errhalt, P; Baumgartner, B; Ambrosch, G; Machan, B; Eckmayr, J; Klikovits, T; Hoda, MA; Popper, H; Klepetko, W; Austrian Mesothelioma Interest Group (AMIG) Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Wien Klin Wochenschr. 2016; 128(17-18):611-617 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hoda, MA; Dong, Y; Rozsas, A; Klikovits, T; Laszlo, V; Ghanim, B; Stockhammer, P; Ozsvar, J; Jakopovic, M; Samarzija, M; Brcic, L; Bendek, M; Szirtes, I; Reid, G; Kirschner, MB; Kao, SC; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TD; Aigner, C; Klepetko, W; van Zandwijk, N; Berger, W; Dome, B; Grusch, M; Hegedus, B Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Eur J Cancer. 2016; 63(1):64-73 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Ghanim, B; Klikovits, T; Hoda, MA; Lang, G; Szirtes, I; Setinek, U; Rozsas, A; Renyi-Vamos, F; Laszlo, V; Grusch, M; Filipits, M; Scheed, A; Jakopovic, M; Samarzija, M; Brcic, L; Stancic-Rokotov, D; Kern, I; Rozman, A; Dekan, G; Klepetko, W; Berger, W; Glasz, T; Dome, B; Hegedus, B Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.
Br J Cancer. 2015; 112(5): 783-792. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Laszlo, V; Hoda, MA; Garay, T; Pirker, C; Ghanim, B; Klikovits, T; Dong, YW; Rozsas, A; Kenessey, I; Szirtes, I; Grusch, M; Jakopovic, M; Samarzija, M; Brcic, L; Kern, I; Rozman, A; Popper, H; Zöchbauer-Müller, S; Heller, G; Altenberger, C; Ziegler, B; Klepetko, W; Berger, W; Dome, B; Hegedus, B Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
J Pathol. 2015; 237(2):203-214
Web of Science PubMed FullText FullText_MUG

 

2014

Arzt, L; Kothmaier, H; Halbwedl, I; Quehenberger, F; Popper, HH Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma.
Virchows Arch. 2014; 465(1):79-88
Web of Science PubMed FullText FullText_MUG

 

Arzt, L; Quehenberger, F; Halbwedl, I; Mairinger, T; Popper, HH BAP1 protein is a progression factor in malignant pleural mesothelioma.
Pathol Oncol Res. 2014; 20(1):145-151
Web of Science PubMed FullText FullText_MUG

 

Brčić, L; Jakopović, M; Brčić, I; Klarić, V; Milošević, M; Sepac, A; Samaržija, M; Seiwerth, S Reproducibility of histological subtyping of malignant pleural mesothelioma.
Virchows Arch. 2014; 465(6): 679-685. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ghanim, B; Hoda, MA; Klikovits, T; Winter, MP; Alimohammadi, A; Grusch, M; Dome, B; Arns, M; Schenk, P; Jakopovic, M; Samarzija, M; Brcic, L; Filipits, M; Laszlo, V; Klepetko, W; Berger, W; Hegedus, B Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.
Br J Cancer. 2014; 110(4): 984-990. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schelch, K; Hoda, MA; Klikovits, T; Münzker, J; Ghanim, B; Wagner, C; Garay, T; Laszlo, V; Setinek, U; Dome, B; Filipits, M; Pirker, C; Heffeter, P; Selzer, E; Tovari, J; Torok, S; Kenessey, I; Holzmann, K; Grasl-Kraupp, B; Marian, B; Klepetko, W; Berger, W; Hegedus, B; Grusch, M Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.
Am J Respir Crit Care Med. 2014; 190(7):763-772
Web of Science PubMed FullText FullText_MUG

 

2013

Lindenmann, J; Matzi, V; Neuboeck, N; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
Interact Cardiovasc Thorac Surg. 2013; 16(3):237-243 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mairinger, F; Vollbrecht, C; Halbwedl, I; Hatz, M; Stacher, E; Gülly, C; Quehenberger, F; Stephan-Falkenau, S; Kollmeier, J; Roth, A; Mairinger, T; Popper, H Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.
J Thorac Oncol. 2013; 8(5):644-653 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Murali, R; Wiesner, T; Scolyer, RA Tumours associated with BAP1 mutations.
Pathology. 2013; 45(2):116-126
Web of Science PubMed FullText FullText_MUG

 

Watzka, SB; Posch, F; Pass, HI; Flores, RM; Hannigan, GE; Bernhard, D; Weber, M; Mueller, MR Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.
Eur J Cardiothorac Surg. 2013; 43(5):940-945 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Hoda, MA; Münzker, J; Ghanim, B; Schelch, K; Klikovits, T; Laszlo, V; Sahin, E; Bedeir, A; Lackner, A; Dome, B; Setinek, U; Filipits, M; Eisenbauer, M; Kenessey, I; Török, S; Garay, T; Hegedus, B; Catania, A; Taghavi, S; Klepetko, W; Berger, W; Grusch, M Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells.
Br J Cancer. 2012; 107(12):1978-1986 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Mairinger, F; Vollbrecht, C; Hatz, M; Stacher, E; Halbwedl, I; Quehenberger, F; Mairinger, T; Popper, HH Association between TS expression levels and response to Pemetrexed in MPM: Fact or fiction?
Proceedings of the 14th World Conference on Lung Cancer, Supplement to Journal of Thoracic Oncology, Supplement 2, Book 2. 2011; 6(6):S981-S982.-14th World Conference on Lung Cancer; JUL 3-7, 2011; Amsterdam, THE NETHERLANDS. [Poster]
Web of Science

 

Watzka, SB; Posch, F; Pass, HI; Huflejt, M; Bernhard, D; Hannigan, GE; Müller, MR Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma.
J Thorac Cardiovasc Surg. 2011; 142(2):384-389 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Watzka, SB; Setinek, U; Stubenberger, EB; Totsch, M; Dekan, G; Marcher, M; Fleck, T; Muller, MR Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma
EUR J CARDIO-THORAC SURG. 2011; 39(2): 180-184. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Lindenmann, J; Matzi, V; Neubock, N; Maier, A; Smolle-Juttner, FM The clinical impact of photodynamic therapy in thoracic surgery
EUR SURG. 2010; 42(5): 220-228.
Web of Science FullText FullText_MUG

 

2008

Dacic, S; Kothmaier, H; Land, S; Shuai, Y; Halbwedl, I; Morbini, P; Murer, B; Comin, C; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, P; Popper, H Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.
Virchows Arch. 2008; 453(6): 627-635.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kelly, KJ; Woo, Y; Brader, P; Yu, Z; Riedl, C; Lin, SF; Chen, N; Yu, YA; Rusch, VW; Szalay, AA; Fong, Y Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.
Hum Gene Ther. 2008; 19(8):774-782 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kothmaier, H; Quehenberger, F; Halbwedl, I; Morbini, P; Demirag, F; Zeren, H; Comin, CE; Murer, B; Cagle, PT; Attanoos, R; Gibbs, AR; Gallateau-Salle, F; Popper, HH EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors.
Thorax. 2008; 63(4):345-351 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Matzi, V; Maier, A; Sankin, O; Lindenmann, J; Woltsche, M; Smolle, J; Smolle-Juttner, FM Photodynamic therapy enhanced by hyperbaric oxygenation in palliation of malignant pleural mesothelioma: Clinical experience.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY. 2004; 1(1): 57-65.
Web of Science FullText FullText_MUG Google Scholar

 

Matzi, V; Maier, A; Woltsche, M; Smolle-Jüttner, FM Polyhematoporphyrin-mediated photodynamic therapy and decortication in palliation of malignant pleural mesothelioma: a clinical pilot study.
Interact Cardiovasc Thorac Surg. 2004; 3(1): 52-56. [OPEN ACCESS]
PubMed FullText FullText_MUG Google Scholar

 

2002

Bongiovanni, M; Viberti, L; Pecchioni, C; Papotti, M; Thonhofer, R; Hans Popper, H; Sapino, A Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells.
J Pathol. 2002; 198(2):252-257
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leithner, A; Weinhaeusel, A; Windhager, R; Schlegl, R; Waldner, P; Lang, S; Dominkus, M; Zoubek, A; Popper, HH; Haas, OA Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas.
Cancer Biol Ther. 2002; 1(4):375-379 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

de Perrot, M; Bründler, M; Tötsch, M; Mentha, G; Morel, P Mesenteric cysts. Toward less confusion?
Dig Surg. 2000; 17(4):323-328
Web of Science PubMed FullText FullText_MUG

 

1996

Schnedl, WJ; Reisinger, EC; Lipp, RW; Uggowitzer, M; Mischinger, HJ; Fickert, P; Krejs, GJ Biliary obstruction due to duodenojejunal intussusception in Peutz-Jeghers syndrome.
J Clin Gastroenterol. 1996; 23(3):220-223 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Trauner, M; Klimpfinger, M; Stauber, RE; Schreiber, F; Stöger, H; Krejs, GJ Laparoscopic diagnosis of peritoneal serous papillary carcinoma.
Endoscopy. 1995; 27(4):337-341 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1994

Preidler, K; Steiner, H; Szolar, D; Kern, R; Kugler, C Malignant peritoneal mesothelioma. Different appearance forms in CT and ultrasound
FORTSCHR RONTGENSTRAHL NEUEN. 1994; 161(2): 174-176. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

PREIDLER, KW; STEINER, H; SZOLAR, D; KERN, R Cystic appearance of a malignant peritoneal mesothelioma by ultrasonography and computed tomography: a case report.
Eur J Radiol. 1994; 18(2):137-139 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1991

Schmid, KW; Hittmair, A; Ofner, C; Tötsch, M; Ladurner, D Metastatic tumors in fine needle aspiration biopsy of the thyroid.
Acta Cytol. 1991; 35(6):722-724
Web of Science PubMed

 

1987

Popper, H; Wirnsberger, G; Hoefler, H; Denk, H Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Cancer Detect Prev. 1987; 10(3-4):167-174
Web of Science PubMed Google Scholar

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum